Type 2 diabetes in patients with end-stage kidney disease: influence on cardiovascular disease-related mortality risk

Wai H. Lim, David W. Johnson, Carmel Hawley, Charmaine Lok, Kevan R. Polkinghorne, Matthew A. Roberts, Neil Boudville, Germaine Wong

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

OBJECTIVES: To examine the association between type 2 diabetes mellitus, with and without diabetic nephropathy, and cardiovascular disease-related mortality in dialysis-dependent patients with end-stage kidney disease (ESKD); to determine whether this association is affected by the age of the patient. DESIGN, SETTING, PARTICIPANTS: Prospective population cohort analysis of Australia and New Zealand Dialysis and Transplant Registry data for all patients with incident ESKD who commenced dialysis in Australia or New Zealand during 1980-2014. OUTCOME MEASURES: Primary outcome: cardiovascular disease-related mortality; secondary outcome: all-cause mortality. RESULTS: Of 56 552 patients followed for a median 2.5 years (total, 193 549 person-years), 15 829 (28.0%) had type 2 diabetes and diabetic nephropathy; 4993 (8.8%) had type 2 diabetes and non-diabetic nephropathy. Cardiovascular disease-related mortality during the first 10 years of dialysis was significantly higher for patients with diabetes/diabetic nephropathy (277 deaths per 1000 patients; 95% CI, 270-284) or diabetes/non-diabetic nephropathy (220 deaths per 1000 patients; 95% CI, 208-231) than for patients without type 2 diabetes (136 deaths per 1000 patients; 95% CI, 133-140). The risk of cardiovascular disease-related mortality was greater for patients with diabetes/diabetic nephropathy (adjusted hazard ratio [aHR], 1.63; 95% CI, 1.56-1.72) or diabetes/non-diabetic nephropathy (aHR, 1.31; 95% CI, 1.23-1.41) than for patients without diabetes. The excess risk associated with having diabetes was greater for younger than for older patients. CONCLUSIONS: Mortality risk is higher for patients with incident ESKD commencing dialysis who also have type 2 diabetes than for patients without diabetes, particularly among patients under 50 years of age, and the risk was more pronounced in patients for whom ESKD was attributed to diabetic nephropathy.

Original languageEnglish
Pages (from-to)440-446
Number of pages7
JournalThe Medical journal of Australia
Volume209
Issue number10
DOIs
Publication statusPublished - 19 Nov 2018

Fingerprint

Type 2 Diabetes Mellitus
Chronic Kidney Failure
Cardiovascular Diseases
Mortality
Diabetic Nephropathies
Dialysis
New Zealand
Registries
Cohort Studies

Cite this

Lim, Wai H. ; Johnson, David W. ; Hawley, Carmel ; Lok, Charmaine ; Polkinghorne, Kevan R. ; Roberts, Matthew A. ; Boudville, Neil ; Wong, Germaine. / Type 2 diabetes in patients with end-stage kidney disease : influence on cardiovascular disease-related mortality risk. In: The Medical journal of Australia. 2018 ; Vol. 209, No. 10. pp. 440-446.
@article{ad054d5b7c1a44b1aea2ff8569185979,
title = "Type 2 diabetes in patients with end-stage kidney disease: influence on cardiovascular disease-related mortality risk",
abstract = "OBJECTIVES: To examine the association between type 2 diabetes mellitus, with and without diabetic nephropathy, and cardiovascular disease-related mortality in dialysis-dependent patients with end-stage kidney disease (ESKD); to determine whether this association is affected by the age of the patient. DESIGN, SETTING, PARTICIPANTS: Prospective population cohort analysis of Australia and New Zealand Dialysis and Transplant Registry data for all patients with incident ESKD who commenced dialysis in Australia or New Zealand during 1980-2014. OUTCOME MEASURES: Primary outcome: cardiovascular disease-related mortality; secondary outcome: all-cause mortality. RESULTS: Of 56 552 patients followed for a median 2.5 years (total, 193 549 person-years), 15 829 (28.0{\%}) had type 2 diabetes and diabetic nephropathy; 4993 (8.8{\%}) had type 2 diabetes and non-diabetic nephropathy. Cardiovascular disease-related mortality during the first 10 years of dialysis was significantly higher for patients with diabetes/diabetic nephropathy (277 deaths per 1000 patients; 95{\%} CI, 270-284) or diabetes/non-diabetic nephropathy (220 deaths per 1000 patients; 95{\%} CI, 208-231) than for patients without type 2 diabetes (136 deaths per 1000 patients; 95{\%} CI, 133-140). The risk of cardiovascular disease-related mortality was greater for patients with diabetes/diabetic nephropathy (adjusted hazard ratio [aHR], 1.63; 95{\%} CI, 1.56-1.72) or diabetes/non-diabetic nephropathy (aHR, 1.31; 95{\%} CI, 1.23-1.41) than for patients without diabetes. The excess risk associated with having diabetes was greater for younger than for older patients. CONCLUSIONS: Mortality risk is higher for patients with incident ESKD commencing dialysis who also have type 2 diabetes than for patients without diabetes, particularly among patients under 50 years of age, and the risk was more pronounced in patients for whom ESKD was attributed to diabetic nephropathy.",
keywords = "Diabetes mellitus, type 2, Kidney diseases, Registries, Renal dialysis",
author = "Lim, {Wai H.} and Johnson, {David W.} and Carmel Hawley and Charmaine Lok and Polkinghorne, {Kevan R.} and Roberts, {Matthew A.} and Neil Boudville and Germaine Wong",
year = "2018",
month = "11",
day = "19",
doi = "10.5694/mja18.00195",
language = "English",
volume = "209",
pages = "440--446",
journal = "Medical Journal Australia",
issn = "0025-729X",
publisher = "Australasian Medical Publishing Co. Ltd",
number = "10",

}

Type 2 diabetes in patients with end-stage kidney disease : influence on cardiovascular disease-related mortality risk. / Lim, Wai H.; Johnson, David W.; Hawley, Carmel; Lok, Charmaine; Polkinghorne, Kevan R.; Roberts, Matthew A.; Boudville, Neil; Wong, Germaine.

In: The Medical journal of Australia, Vol. 209, No. 10, 19.11.2018, p. 440-446.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Type 2 diabetes in patients with end-stage kidney disease

T2 - influence on cardiovascular disease-related mortality risk

AU - Lim, Wai H.

AU - Johnson, David W.

AU - Hawley, Carmel

AU - Lok, Charmaine

AU - Polkinghorne, Kevan R.

AU - Roberts, Matthew A.

AU - Boudville, Neil

AU - Wong, Germaine

PY - 2018/11/19

Y1 - 2018/11/19

N2 - OBJECTIVES: To examine the association between type 2 diabetes mellitus, with and without diabetic nephropathy, and cardiovascular disease-related mortality in dialysis-dependent patients with end-stage kidney disease (ESKD); to determine whether this association is affected by the age of the patient. DESIGN, SETTING, PARTICIPANTS: Prospective population cohort analysis of Australia and New Zealand Dialysis and Transplant Registry data for all patients with incident ESKD who commenced dialysis in Australia or New Zealand during 1980-2014. OUTCOME MEASURES: Primary outcome: cardiovascular disease-related mortality; secondary outcome: all-cause mortality. RESULTS: Of 56 552 patients followed for a median 2.5 years (total, 193 549 person-years), 15 829 (28.0%) had type 2 diabetes and diabetic nephropathy; 4993 (8.8%) had type 2 diabetes and non-diabetic nephropathy. Cardiovascular disease-related mortality during the first 10 years of dialysis was significantly higher for patients with diabetes/diabetic nephropathy (277 deaths per 1000 patients; 95% CI, 270-284) or diabetes/non-diabetic nephropathy (220 deaths per 1000 patients; 95% CI, 208-231) than for patients without type 2 diabetes (136 deaths per 1000 patients; 95% CI, 133-140). The risk of cardiovascular disease-related mortality was greater for patients with diabetes/diabetic nephropathy (adjusted hazard ratio [aHR], 1.63; 95% CI, 1.56-1.72) or diabetes/non-diabetic nephropathy (aHR, 1.31; 95% CI, 1.23-1.41) than for patients without diabetes. The excess risk associated with having diabetes was greater for younger than for older patients. CONCLUSIONS: Mortality risk is higher for patients with incident ESKD commencing dialysis who also have type 2 diabetes than for patients without diabetes, particularly among patients under 50 years of age, and the risk was more pronounced in patients for whom ESKD was attributed to diabetic nephropathy.

AB - OBJECTIVES: To examine the association between type 2 diabetes mellitus, with and without diabetic nephropathy, and cardiovascular disease-related mortality in dialysis-dependent patients with end-stage kidney disease (ESKD); to determine whether this association is affected by the age of the patient. DESIGN, SETTING, PARTICIPANTS: Prospective population cohort analysis of Australia and New Zealand Dialysis and Transplant Registry data for all patients with incident ESKD who commenced dialysis in Australia or New Zealand during 1980-2014. OUTCOME MEASURES: Primary outcome: cardiovascular disease-related mortality; secondary outcome: all-cause mortality. RESULTS: Of 56 552 patients followed for a median 2.5 years (total, 193 549 person-years), 15 829 (28.0%) had type 2 diabetes and diabetic nephropathy; 4993 (8.8%) had type 2 diabetes and non-diabetic nephropathy. Cardiovascular disease-related mortality during the first 10 years of dialysis was significantly higher for patients with diabetes/diabetic nephropathy (277 deaths per 1000 patients; 95% CI, 270-284) or diabetes/non-diabetic nephropathy (220 deaths per 1000 patients; 95% CI, 208-231) than for patients without type 2 diabetes (136 deaths per 1000 patients; 95% CI, 133-140). The risk of cardiovascular disease-related mortality was greater for patients with diabetes/diabetic nephropathy (adjusted hazard ratio [aHR], 1.63; 95% CI, 1.56-1.72) or diabetes/non-diabetic nephropathy (aHR, 1.31; 95% CI, 1.23-1.41) than for patients without diabetes. The excess risk associated with having diabetes was greater for younger than for older patients. CONCLUSIONS: Mortality risk is higher for patients with incident ESKD commencing dialysis who also have type 2 diabetes than for patients without diabetes, particularly among patients under 50 years of age, and the risk was more pronounced in patients for whom ESKD was attributed to diabetic nephropathy.

KW - Diabetes mellitus, type 2

KW - Kidney diseases

KW - Registries

KW - Renal dialysis

UR - http://www.scopus.com/inward/record.url?scp=85056637280&partnerID=8YFLogxK

U2 - 10.5694/mja18.00195

DO - 10.5694/mja18.00195

M3 - Article

VL - 209

SP - 440

EP - 446

JO - Medical Journal Australia

JF - Medical Journal Australia

SN - 0025-729X

IS - 10

ER -